Insulin degludec improves health-related quality of life (SF-36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials

Aim To compare the effect of insulin degludec and insulin glargine on health-related quality of life in patients with Type 2 diabetes starting on insulin therapy. Methods Patient-level data from three open-label, randomized, treat-to-target trials of 26 or 52 weeks' duration were pooled using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Freemantle, N, Meneghini, L, Christensen, T, Wolden, M L, Jendle, J, Ratner, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Inc 2013
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579236/
https://www.ncbi.nlm.nih.gov/pubmed/23199058
http://dx.doi.org/10.1111/dme.12086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579236/
https://www.ncbi.nlm.nih.gov/pubmed/23199058
http://dx.doi.org/10.1111/dme.12086

Ejemplares similares